Clinical Research Directory
Browse clinical research sites, groups, and studies.
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
Sponsor: Ning Xu
Summary
This study was designed as a prospective, multicentre, double-blind, randomised controlled clinical trial. It aims to investigate the feasibility and safety of the posterior approach extrafascial technique and the anterior approach extrafascial technique in robot-assisted radical prostatectomy (RARP) for intermediate- and high-risk prostate cancer patients, to compare the oncological prognosis, functional prognosis, and safety of the two techniques in intermediate- and high-risk prostate cancer patients, and to provide evidence-based medical evidence for the choice of surgical treatment modality for intermediate- and high-risk prostate cancer patients.
Official title: Application of the Extra-fascial Robot Assisted Radical Prostatectomy Via the Posterior Approach in Intermediate or High Risk Patients: a Prospective, Multicenter, Double-blind, Randomized Controlled Study
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
118
Start Date
2024-07-01
Completion Date
2026-12-31
Last Updated
2025-09-15
Healthy Volunteers
No
Interventions
Extrafascial robotic assisted radical prostatectomy via posterior approach
Extrafascial robotic assisted radical prostatectomy via posterior approach will be applied in the intermediate or high risk patients.
Extrafascial robotic assisted radical prostatectomy via anterior approach
Extrafascial robotic assisted radical prostatectomy via anterior approach will be applied in the intermediate or high risk patients.
Locations (1)
first hospital affiliated of Fujian medical university
Fuzhou, Fujian, China